doi: 10.3390/ijms160818185 197
After just four months of treatment: Postmenopausal women lost an average of 13 pounds Premenopausal women lost an average of 10 pounds Fat mass dropped significantly in both groups Lean mass remained largely preserved Emotional eating dropped from nearly 7080% to around 12% Sweet cravings fell dramatically to single-digit percentages What makes this especially relevant for women in menopause is this: despite starting with higher baseline weight and fat mass, postmenopausal women achieved results comparable to younger women
Because retatrutide adds glucagon receptor activation, it requires close tracking of transient heart rate changes, and early data suggests its gastrointestinal side effects may occur slightly more frequently at the highest clinical doses
The companys defense could point out that other things in a patients life may have led to their health issues, not just Ozempic
Altered Food Preferences: Some individuals report changes in taste perception, particularly a reduced preference for fatty and highly processed foods, suggesting GLP-1 medications reshape dietary behavior beyond just appetite suppression
This reduction does have side effects such as decreased muscle mass, increased risk of cardiovascular diseases, etc